An update on pharmacotherapy for recurrent depression in 2022

References

• Otte C, Gold SM, Penninx BW, et al. Major depressive disorder. Nat Rev Dis Primers. 2016 Sep 15;2:16065. doi: 10.1038/nrdp.2016.65 PMID: 27629598
   PubMed Web of Science ®Google Scholar
• Lépine JP, Briley M. The increasing burden of depression. Neuropsychiatr Dis Treat. 2011;7(Suppl 1):3–7. doi: 10.2147/NDT.S19617 Epub 2011 May 31. PMID: 21750622; PMCID: PMC3131101
   PubMedGoogle Scholar
• Judd LL. The clinical course of unipolar major depressive disorders. Arch Gen Psychiatry. 1997 Nov;54(11):989–991. doi: 10.1001/archpsyc.1997.01830230015002 PMID: 9366654.
   PubMed Web of Science ®Google Scholar
• Fava GA, Fabbri S, Sonino N. Residual symptoms in depression: an emerging therapeutic target. Prog Neuropsychopharmacol Biol Psychiatry. 2002 Oct;26(6):1019–1027. doi: 10.1016/s0278-5846(02)00226-9 PMID: 12452521.
   PubMed Web of Science ®Google Scholar
• Fava GA, Ruini C, Sonino N. Treatment of recurrent depression: a sequential psychotherapeutic and psychopharmacological approach. CNS Drugs. 2003;17(15):1109–1117. doi: 10.2165/00023210-200317150-00005 PMID: 14661988.
   PubMed Web of Science ®Google Scholar
• Frank E, Prien RF, Jarrett RB, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry. 1991 Sep;48(9):851–855. PMID: 1929776. doi: 10.1001/archpsyc.1991.01810330075011
   PubMed Web of Science ®Google Scholar
• Solomon DA, Keller MB, Leon AC, et al. Multiple recurrences of major depressive disorder. Am J Psychiatry. 2000 Feb;157(2):229–233. PMID: 10671391. doi: 10.1176/appi.ajp.157.2.229
   PubMed Web of Science ®Google Scholar
• Kessler RC, Berglund P, Demler O, et al. National comorbidity survey replication. the epidemiology of major depressive disorder: results from the national comorbidity survey replication (NCS-R). JAMA. 2003 Jun 18;289(23):3095–3105. PMID: 12813115. doi: 10.1001/jama.289.23.3095
   PubMed Web of Science ®Google Scholar
• Lin EH, Katon WJ, VonKorff M, et al. Relapse of depression in primary care. Rate and clinical predictors. Arch Fam Med. 1998 Sep;7(5):443–449. PMID: 9755737. doi: 10.1001/archfami.7.5.443
   PubMedGoogle Scholar
• Buckman JEJ, Underwood A, Clarke K, et al. Risk factors for relapse and recurrence of depression in adults and how they operate: a four-phase systematic review and meta-synthesis. Clin Psychol Rev. 2018 Aug;64:13–38. Epub 2018 Jul 29. PMID: 30075313; PMCID: PMC6237833. doi: 10.1016/j.cpr.2018.07.005
   PubMed Web of Science ®Google Scholar
• Kennis M, Gerritsen L, van Dalen M, et al. Prospective biomarkers of major depressive disorder: a systematic review and meta-analysis. Mol Psychiatry. 2020 Feb;25(2):321–338. Epub 2019 Nov 19. PMID: 31745238; PMCID: PMC6974432. doi: 10.1038/s41380-019-0585-z
   PubMed Web of Science ®Google Scholar
• Stetler C, Miller GE. Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom Med. 2011 Feb;73(2):114–126. Epub 2011 Jan 21. PMID: 21257974. doi: 10.1097/PSY.0b013e31820ad12b
   PubMed Web of Science ®Google Scholar
• Moriarty AS, Meader N, Snell KIE, et al. Predicting relapse or recurrence of depression: systematic review of prognostic models. Br J Psychiatry. 2022 Aug;221(2):448–458. PMID: 35048843. doi: 10.1192/bjp.2021.218
   PubMed Web of Science ®Google Scholar
• Rush AJ, Kraemer HC, Sackeim HA, et al. ACNP Task Force. Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology. 2006 Sep;31(9):1841–1853. Epub 2006 Jun 21. PMID: 16794566. doi: 10.1038/sj.npp.1301131
   PubMed Web of Science ®Google Scholar
• Hirschfeld RM. Guidelines for the long-term treatment of depression. J Clin Psychiatry. 1994 Dec;55:61–69. discussion 70-1. PMID: 7814359.
   PubMed Web of Science ®Google Scholar
• Kupfer DJ. Long-term treatment of depression. J Clin Psychiatry. 1991 May;52:28–34. PMID: 1903134.
   PubMed Web of Science ®Google Scholar
• Keller MB. The long-term treatment of depression. J Clin Psychiatry. 1999;60(17):41–45. discussion 46-8. PMID: 10446742.
   PubMedGoogle Scholar
• Severe J, Greden JF, Reddy P. Consequences of Recurrence of Major Depressive Disorder: is Stopping Effective Antidepressant Medications Ever Safe? Focus (Am Psychiatr Publ). 2020 Apr;18(2):120–128. Epub 2020 Apr 23. PMID: 33162849; PMCID: PMC7587881. doi: 10.1176/appi.focus.20200008
   PubMedGoogle Scholar
• Fava GA, Ruini C, Rafanelli C. Sequential treatment of mood and anxiety disorders. J Clin Psychiatry. 2005 Nov;66(11):1392–1400. PMID: 16420076. doi: 10.4088/jcp.v66n1108
   PubMed Web of Science ®Google Scholar
• Sim K, Lau WK, Sim J, et al. Prevention of relapse and recurrence in adults with major depressive disorder: systematic review and meta-analyses of controlled trials. Int J Neuropsychopharmacol. 2015 Jul 7;19(2):yv076. Erratum in: Int J Neuropsychopharmacol. 2016 Apr 27; PMID: 26152228; PMCID: PMC4772815. doi: 10.1093/ijnp/pyv076
   Web of Science ®Google Scholar
• Sterzer P. Born to be criminal? What to make of early biological risk factors for criminal behavior. Am J Psychiatry. 2010;167(suppl 10):1–3. doi: 10.1176/appi.ajp.2009.09111601
   PubMedGoogle Scholar
• Cleare A, Pariante CM, Young AH, et al. Members of the Consensus Meeting. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines. J Psychopharmacol. 2015 May;29(5):459–525. Epub 2015 May 12. PMID: 25969470. doi: 10.1177/0269881115581093
   PubMed Web of Science ®Google Scholar
• Wilkinson P, Izmeth Z. Continuation and maintenance treatments for depression in older people. Cochrane Database Syst Rev. 2016 Sep 9;9(9):CD006727. doi: 10.1002/14651858.CD006727.pub3 PMID: 27609183; PMCID: PMC6457610
   PubMedGoogle Scholar
• Van Leeuwen E, van Driel ML, Horowitz MA, et al. Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults. Cochrane Database Syst Rev. 2021 Apr 15;4(4):CD013495. PMID: 33886130; PMCID: PMC8092632. doi: 10.1002/14651858.CD013495.pub2
   PubMedGoogle Scholar
• Fava GA. Can long-term treatment with antidepressant drugs worsen the course of depression? J Clin Psychiatry. 2003 Feb;64(2):123–133. PMID: 12633120. doi: 10.4088/jcp.v64n0204
   PubMed Web of Science ®Google Scholar
• Andrews PW, Kornstein SG, Halberstadt LJ, et al. Blue again: perturbational effects of antidepressants suggest monoaminergic homeostasis in major depression. Front Psychol. 2011 Jul 7;2:159. PMID: 21779273; PMCID: PMC3133866. doi: 10.3389/fpsyg.2011.00159
   PubMed Web of Science ®Google Scholar
• Andrews PW, Thomson JA, Amstadter A, et al. Primum non-nocere: an evolutionary analysis of whether antidepressants do more harm than good. Front Psychology. 2012;3:1–19. doi: 10.3389/fpsyg.2012.00117
   PubMed Web of Science ®Google Scholar
• Posternak MA, Zimmerman M. Dual reuptake inhibitors incur lower rates of tachyphylaxis than selective serotonin reuptake inhibitors: a retrospective study. J Clin Psychiatry. 2005 Jun;66(6):705–707. PMID: 15960562. doi: 10.4088/jcp.v66n0605
   PubMed Web of Science ®Google Scholar
• Hengartner MP, Passalacqua S, Andreae A, et al. Antidepressant use during acute inpatient care is associated with an increased risk of psychiatric rehospitalisation over a 12-month follow-up after discharge. Front Psychiatry. 2019 [Published 2019 Feb 22];10:79.
   PubMed Web of Science ®Google Scholar
• Fava GA, Cosci F. Understanding and managing withdrawal syndromes after discontinuation of antidepressant drugs. J Clin Psychiatry. 2019 Published 2019 Nov 26;80(6):19com12794. doi: 10.4088/JCP.19com12794
   PubMed Web of Science ®Google Scholar
• Récalt AM, Cohen D. Withdrawal confounding in randomized controlled trials of antipsychotic, antidepressant, and stimulant drugs, 2000-2017. Psychother Psychosom. 2019;88(2):105–113. doi: 10.1159/000496734
   PubMed Web of Science ®Google Scholar
• Eveleigh R, Speckens A, van Weel C, et al. Patients’ attitudes to discontinuing not-indicated long-term antidepressant use: barriers and facilitators. Ther Adv Psychopharmacol. 2019 [Published 2019 Sep 3];9:2045125319872344.
   Web of Science ®Google Scholar
• Kaymaz N, van Os J, Loonen AJ, et al. Evidence that patients with single versus recurrent depressive episodes are differentially sensitive to treatment discontinuation: a meta-analysis of placebo-controlled randomized trials. J Clin Psychiatry. 2008;69(9):1423–1436. doi: 10.4088/jcp.v69n0910
   PubMed Web of Science ®Google Scholar
• Carvalho AF, Sharma MS, Brunoni AR, et al. The safety, tolerability and risks associated with the use of newer generation antidepressant drugs: a critical review of the literature. Psychother Psychosom. 2016;85(5):270–288. doi: 10.1159/000447034
   PubMed Web of Science ®Google Scholar
• van Straten A, Geraedts A, Verdonck-de Leeuw I, et al. Psychological treatment of depressive symptoms in patients with medical disorders: a meta-analysis. J Psychosom Res. 2010;69(1):23–32. doi: 10.1016/j.jpsychores.2010.01.019
   PubMed Web of Science ®Google Scholar
• Bobo WV, Vande Voort JL, Croarkin PE, et al. Ketamine for treatment-resistant unipolar and bipolar major depression: critical review and implications for clinical practice. Depress Anxiety. 2016 Aug;33(8):698–710. Epub 2016 Apr 6. PMID: 27062450. doi: 10.1002/da.22505
   PubMed Web of Science ®Google Scholar
• Kryst J, Kawalec P, Mitoraj AM, et al. Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: a meta-analysis of randomized clinical trials. Pharmacol Rep. 2020 Jun;72(3):543–562. Epub 2020 Apr 16. PMID: 32301056; PMCID: PMC7329804. doi: 10.1007/s43440-020-00097-z
   PubMed Web of Science ®Google Scholar
• Papakostas GI. Maintaining rapid antidepressant effects following ketamine infusion: a major unmet need. J Clin Psychiatry. 2020 Feb 4;81(2):19r12859. doi: 10.4088/JCP.19r12859 PMID: 32023369.
   PubMed Web of Science ®Google Scholar
• Smith-Apeldoorn SY, Veraart JK, Spijker J, et al. Maintenance ketamine treatment for depression: a systematic review of efficacy, safety, and tolerability. Lancet Psychiatry. 2022 Nov;9(11):907–921. PMID: 36244360. doi: 10.1016/S2215-0366(22)00317-0
   PubMed Web of Science ®Google Scholar
• UK ECT Review Group. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet. 2003 Mar 8;361(9360):799–808. doi: 10.1016/S0140-6736(03)12705-5 PMID: 12642045
   PubMed Web of Science ®Google Scholar
• Jelovac A, Kolshus E, McLoughlin DM. Relapse following successful electroconvulsive therapy for major depression: a meta-analysis. Neuropsychopharmacology. 2013 Nov;38(12):2467–2474. Epub 2013 Jun 18. PMID: 23774532; PMCID: PMC3799066. doi: 10.1038/npp.2013.149
   PubMed Web of Science ®Google Scholar
• Sackeim HA, Haskett RF, Mulsant BH, et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA. 2001 Mar 14;285(10):1299–1307. PMID: 11255384. doi: 10.1001/jama.285.10.1299
   PubMed Web of Science ®Google Scholar
• Gueorguieva R, Chekroud AM, Krystal JH. Trajectories of relapse in randomised, placebo-controlled trials of treatment discontinuation in major depressive disorder: an individual patient-level data meta-analysis. Lancet Psychiatry. 2017 Mar;4(3):230–237. Epub 2017 Feb 9. PMID: 28189575; PMCID: PMC5340978. doi: 10.1016/S2215-0366(17)30038-X
   PubMed Web of Science ®Google Scholar
• Kellner CH, Knapp RG, Petrides G, et al. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry. 2006 Dec;63(12):1337–1344. PMID: 17146008; PMCID: PMC3708140. doi: 10.1001/archpsyc.63.12.1337
   PubMed Web of Science ®Google Scholar
• Lisanby SH, Sampson S, Husain MM, et al. Toward individualized post-electroconvulsive therapy care: piloting the Symptom-Titrated, Algorithm-Based Longitudinal ECT (STABLE) intervention. J Ect. 2008 Sep;24(3):179–182. PMID: 18708943; PMCID: PMC2743247. doi: 10.1097/YCT.0b013e318185fa6b
   PubMed Web of Science ®Google Scholar
• Wassermann EM, Lisanby SH. Therapeutic application of repetitive transcranial magnetic stimulation: a review. Clin Neurophysiol. 2001 Aug;112(8):1367–1377. PMID: 11459676. doi: 10.1016/s1388-2457(01)00585-5
   PubMed Web of Science ®Google Scholar
• Hallett M. Transcranial magnetic stimulation: a primer. Neuron. 2007 Jul 19;55(2):187–199. doi: 10.1016/j.neuron.2007.06.026 PMID: 17640522.
   PubMed Web of Science ®Google Scholar
• Wagner T, Valero-Cabre A, Pascual-Leone A. Noninvasive human brain stimulation. Annu Rev Biomed Eng. 2007;9:527–565. PMID: 17444810. doi: 10.1146/annurev.bioeng.9.061206.133100
   PubMed Web of Science ®Google Scholar
• Berlim MT, Van den Eynde F, Jeff Daskalakis Z. Clinically meaningful efficacy and acceptability of low-frequency repetitive transcranial magnetic stimulation (rTMS) for treating primary major depression: a meta-analysis of randomized, double-blind and sham-controlled trials. Neuropsychopharmacology. 2013 Mar;38(4):543–551. Epub 2012 Nov 19. PMID: 23249815; PMCID: PMC3572468. doi: 10.1038/npp.2012.237
   PubMed Web of Science ®Google Scholar
• Chen J, Zhou C, Wu B, et al. Left versus right repetitive transcranial magnetic stimulation in treating major depression: a meta analysis of randomised controlled trials. Psychiatry Res. 210(3): Epub 2013 Oct 7. PMID: 24113125:1260–1264. 2013 Dec 30. doi: 10.1016/j.psychres.2013.09.007
   PubMed Web of Science ®Google Scholar
• Gaynes BN, Lloyd SW, Lux L, et al. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis. J Clin Psychiatry. 2014 May;75(5):477–489. quiz 489 PMID: 24922485. doi: 10.4088/JCP.13r08815
   PubMed Web of Science ®Google Scholar
• Dell’osso B, D’Urso N, Castellano F, et al. Long-term efficacy after acute augmentative repetitive transcranial magnetic stimulation in bipolar depression: a 1-year follow-up study. J Ect. 2011 Jun;27(2):141–144. PMID: 20966770. doi: 10.1097/YCT.0b013e3181f66601
   PubMed Web of Science ®Google Scholar
• Richieri R, Guedj E, Michel P, et al. Maintenance transcranial magnetic stimulation reduces depression relapse: a propensity-adjusted analysis. J Affect Disord. 2013 Oct;151(1):129–135. Epub 2013 Jun 18. PMID: 23790811. doi: 10.1016/j.jad.2013.05.062
   PubMed Web of Science ®Google Scholar
• Nierenberg AA, Petersen TJ, Alpert JE. Prevention of relapse and recurrence in depression: the role of long-term pharmacotherapy and psychotherapy. J Clin Psychiatry. 2003;64(15):13–17. PMID: 14658986.
   PubMed Web of Science ®Google Scholar
• Guidi J, Tomba E, Fava GA. The sequential integration of pharmacotherapy and psychotherapy in the treatment of major depressive disorder: a meta-analysis of the sequential model and a critical review of the literature. Am J Psychiatry. 173(2): Epub 2015 Oct 20. PMID: 26481173:128–137. 2016 Feb 1. doi: 10.1176/appi.ajp.2015.15040476
   PubMed Web of Science ®Google Scholar
• Dobson KS, Hollon SD, Dimidjian S, et al. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the prevention of relapse and recurrence in major depression. J Consult Clin Psychol. 2008 Jun;76(3):468–477. PMID: 18540740; PMCID: PMC2648513. doi: 10.1037/0022-006X.76.3.468
   PubMed Web of Science ®Google Scholar
• Segal ZV, Bieling P, Young T, et al. Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression. Arch Gen Psychiatry. 2010 Dec;67(12):1256–1264. PMID: 21135325; PMCID: PMC3311113. doi: 10.1001/archgenpsychiatry.2010.168
   PubMed Web of Science ®Google Scholar
• Ma SH, Teasdale JD. Mindfulness-based cognitive therapy for depression: replication and exploration of differential relapse prevention effects. J Consult Clin Psychol. 2004 Feb;72(1):31–40. PMID: 14756612. doi: 10.1037/0022-006X.72.1.31
   PubMed Web of Science ®Google Scholar
• Kuyken W, Byford S, Taylor RS, et al. Mindfulness-based cognitive therapy to prevent relapse in recurrent depression. J Consult Clin Psychol. 2008 Dec;76(6):966–978. PMID: 19045965. doi: 10.1037/a0013786
   PubMed Web of Science ®Google Scholar
• Bondolfi G, Jermann F, der Linden MV, et al. Depression relapse prophylaxis With mindfulness-based cognitive therapy: replication and extension in the Swiss health care system. J Affect Disord. 2010 May;122(3):224–231. Epub 2009 Aug 8. PMID: 19666195; PMCID: PMC2866251. doi: 10.1016/j.jad.2009.07.007
   PubMed Web of Science ®Google Scholar
• Mathew KL, Whitford HS, Kenny MA, et al. The long-term effects of mindfulness-based cognitive therapy as a relapse prevention treatment for major depressive disorder. Behav Cogn Psychother. 2010 Oct;38(5):561–576. Epub 2010 Apr 7. PMID: 20374671. doi: 10.1017/S135246581000010X
   PubMed Web of Science ®Google Scholar
• Kelin K, Berk M, Spann M, et al. Duloxetine 60 mg/day for the prevention of depressive recurrences: post hoc analyses from a recurrence prevention study. Int J Clin Pract. 2010 May;64(6):719–726. Epub 2010 Mar 23. PMID: 20345508. doi:10.1111/j.1742-1241.2010.02374.x
   PubMed Web of Science ®Google Scholar
• Bockting CL, Schene AH, Spinhoven P, et al. Preventing relapse/recurrence in recurrent depression with cognitive therapy: a randomized controlled trial. J Consult Clin Psychol. 2005 Aug;73(4):647–657. PMID: 16173852. doi: 10.1037/0022-006X.73.4.647
   PubMed Web of Science ®Google Scholar
• Bockting CL, Spinhoven P, Wouters LF, et al.Long-term effects of preventive cognitive therapy in recurrent depression: a 5.5-year follow-up study. J Clin Psychiatry. 2009 Dec;70(12):1621–1628. PMID: 20141705.`. doi: 10.4088/JCP.08m04784blu
   PubMed Web of Science ®Google Scholar
• Rosenthal NE, Sack DA, Gillin JC, et al. Seasonal affective disorder - a description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry. 1984;41(1):72–80. doi: 10.1001/archpsyc.1984.01790120076010
   PubMed Web of Science ®Google Scholar
• Modell JG, Rosenthal NE, Harriett AE, et al. Seasonal affective disorder and its prevention by anticipatory treatment with bupropion XL. Biol Psychiatry. 2005;58(8):658–667. doi: 10.1016/j.biopsych.2005.07.021
   PubMed Web of Science ®Google Scholar
• Niemegeers P, Dumont GJ, Patteet L, et al. Bupropion for the treatment of seasonal affective disorder. Expert Opin Drug Metab Toxicol. 2013 Sep;9(9):1229–1240. doi: 10.1517/17425255.2013.804062
   PubMed Web of Science ®Google Scholar
• Gartlehner G, Nussbaumer-Streit B, Gaynes BN, et al. Second-generation antidepressants for preventing seasonal affective disorder in adults. Cochrane Database Syst Rev. 2019 Mar 18;3(3):CD011268. doi: 10.1002/14651858.CD011268.pub3
   PubMedGoogle Scholar
• Nussbaumer-Streit B, Forneris CA, Morgan LC, et al. Light therapy for preventing seasonal affective disorder. Cochrane Database Syst Rev. 2019 Mar 18;3(3):CD011269. doi: 10.1002/14651858.CD011269.pub3 PMID: 30883670; PMCID: PMC6422319
   PubMedGoogle Scholar
• Nussbaumer-Streit B, Greenblatt A, Kaminski-Hartenthaler A, et al. Melatonin and agomelatine for preventing seasonal affective disorder. Cochrane Database Syst Rev. 2019 Jun 17;6(6):CD011271. doi: 10.1002/14651858.CD011271.pub3 PMID: 31206585; PMCID: PMC6578031
   PubMedGoogle Scholar
• Forneris CA, Nussbaumer-Streit B, Morgan LC, et al. Psychological therapies for preventing seasonal affective disorder. Cochrane Database Syst Rev. 2019 May 24;5(5):CD011270. doi: 10.1002/14651858.CD011269.pub3 PMID: 31124141; PMCID: PMC6533196
   PubMedGoogle Scholar
• Babyak M, Blumenthal JA, Herman S, et al. Exercise treatment for major depression: maintenance of therapeutic benefit at 10 months. Psychosom Med. 2000;62(5):633–638. doi: 10.1097/00006842-200009000-00006
   PubMed Web of Science ®Google Scholar